Jennifer F. Bos

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease.

Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease.

Journal: American journal of hematology

Published: November 19, 2024

Omega-3 supplementation changes the physical properties of leukocytes but not erythrocytes in healthy individuals: An exploratory trial.

Omega-3 supplementation changes the physical properties of leukocytes but not erythrocytes in healthy individuals: An exploratory trial.

Journal: Prostaglandins, leukotrienes, and essential fatty acids

Published: May 28, 2024

Osmotic gradient ektacytometry - a novel diagnostic approach for neuroacanthocytosis syndromes.

Osmotic gradient ektacytometry - a novel diagnostic approach for neuroacanthocytosis syndromes.

Journal: Frontiers in neuroscience

Published: March 25, 2024

Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.

Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.

Journal: HemaSphere

Published: January 30, 2024

A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease.

A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease.

Journal: EJHaem

Published: October 24, 2023

One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.

One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.

Journal: Blood advances

Published: August 18, 2023

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.

Journal: International journal of laboratory hematology

Published: June 26, 2023

Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.

Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.

Journal: Blood advances

Published: June 21, 2023

A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia.

A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia.

Journal: American journal of hematology

Published: June 07, 2023

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.

Journal: American journal of hematology

Published: March 10, 2022

Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.

Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.

Journal: Cells

Published: March 08, 2021

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis.

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis.

Journal: Frontiers in physiology

Published: December 14, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026